Search
for
Sort by
Research 871–900 of 1000+
- Criteria for Commencing and Continuing Subsidised Janus Kinase Inhibitor Therapy in Australian Alopecia Areata Patients—Results From an Australian Expert Consensus Exercise
- The Current State of Patient Adherence to Lab Monitoring Guidelines for Janus Kinase Inhibitors in Patients with Alopecia Areata.
- Comparative Study between Intralesional Pentoxifylline and Steroid in Localized Alopecia Areata
- Alopecia areata: Time for position statement to include new systemic therapeutic advances
- Case report: Dupilumab therapy for alopecia areata in a 4-year-old patient resistant to baricitinib
- The pharmacological treatment of alopecia areata
- Trichoscopy pattern and evaluation of serum vitamin D status in alopecia areata
- The usefulness and wellbeing of Tofacitinib in the treatment of Alopecia Areata
- Immunohistochemical study assessing stem cell factor receptor C-kit in patients with alopecia
- Health-related quality of life in mild-moderate patchy alopecia areata: Results from the first controlled Phase 2 clinical trial in this population with STS01 (dithranol/ProSilic) and challenges for the future
- Intralesional Platelet-Rich Plasma Injection in Patients with Recalcitrant Alopecia Areata
- Alopecia universalis following human papillomavirus vaccine administration: a case report
- Diagnosis and differential diagnosis of tertiary androgenetic alopecia with severe alopecia areata based on high‐resolution MRI
- A Large Cross-Sectional Survey Study of the Prevalence of Alopecia Areata in the United States
- Tofacitinib (Selective Janus Kinase Inhibitor 1 and 3): A promising therapy for the treatment of alopecia areata: A case report of six patients
- Classification Framework for Healthy Hairs and Alopecia Areata: A Machine Learning (ML) Approach
- A retrospective analysis of disease epidemiology, comorbidities, treatment patterns, and healthcare resource utilization of alopecia areata in the United Arab Emirates using claims database
- Physician- and Patient-Reported Severity and Quality of Life Impact of Alopecia Areata: Results from a Real-World Survey in Five European Countries
- A randomized comparative study of the efficacy of topical latanoprost versus topical betamethasone diproprionate lotion in the treatment of localized alopecia areata
- Troponin I in alopecia areata and female pattern hair loss
- Assessing Alopecia Areata Management in Poland: Challenges in Medical Practices and Patient Care
- Autophagy and alopecia areata: is there a link?
- Approach to Managing Recalcitrant Alopecia Areata with Combination Therapy: A Series of Five Cases in Black Pediatric Patients
- Illness Perception, Emotional Distress, and Obsessive–Compulsive Symptomatology in Patients with Alopecia Areata: A Mediation Study
- Enhanced Hair Regrowth with Five Monthly Sessions of Minoxidil-Dutasteride-Copper Peptides Tattooing for Androgenetic Alopecia Assessed by Artificial Intelligence and Blinded Evaluators
- Platelet-rich plasma and topical minoxidil 5% in the treatment of severe alopecia areata: Report of two cases
- Non-Scarring Alopecia in Females: A Comprehensive Review
- Are Janus kinase (JAK) inhibitors beneficial in the treatment of androgenic alopecia?
- Quality of life in patients with scarring and non‐scarring alopecia: An exploratory cross‐sectional study
- Utility of trichoscopy in comparison to the standard methods for assessing the disease activity, severity, and therapeutic response in alopecia areata